Elevation of liver function tests (LFTs) has been noted in patients treated with sirolimus. However, in the United States [1] and global phase 3 trials, [2] elevation of LFTs, specifically of AST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback